Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.
Gayà-Barroso A, González-Moreno J, Rodríguez A, Ripoll-Vera T, Losada-López I, Gili M, Cisneros-Barroso E. Gayà-Barroso A, et al. Among authors: losada lopez i. Int J Environ Res Public Health. 2022 Apr 7;19(8):4464. doi: 10.3390/ijerph19084464. Int J Environ Res Public Health. 2022. PMID: 35457333 Free PMC article.
[IgG4-related disease].
González-Moreno J, Losada López I, Ortego Centeno N. González-Moreno J, et al. Med Clin (Barc). 2015 Dec 21;145(12):539-44. doi: 10.1016/j.medcli.2014.12.017. Epub 2015 Feb 25. Med Clin (Barc). 2015. PMID: 25726306 Review. Spanish.
Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
Cisneros-Barroso E, Losada-López I, González-Moreno J, Buades J, Ferrer-Nadal A, Ripoll-Vera T, Usón M, Figuerola A, Montalà JC, Descals C, Salva-Ramonell F, Torres-Rovira J, Gene-Heym A, Fernández-Burgos I, Soler T. Cisneros-Barroso E, et al. Amyloid. 2019;26(sup1):59-60. doi: 10.1080/13506129.2019.1582521. Amyloid. 2019. PMID: 31343326 No abstract available.
Association between aortic stenosis and hereditary transthyretin amyloidosis.
Ripoll-Vera T, Álvarez Rubio J, Iglesias M, Losada López I, Ferrer-Nadal A, González Moreno J. Ripoll-Vera T, et al. Rev Esp Cardiol (Engl Ed). 2021 Feb;74(2):185-187. doi: 10.1016/j.rec.2020.05.037. Epub 2020 Aug 7. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32778403 English, Spanish. No abstract available.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
22 results